S.R. Kottegoda

806 total citations
36 papers, 610 citations indexed

About

S.R. Kottegoda is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmacology. According to data from OpenAlex, S.R. Kottegoda has authored 36 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pediatrics, Perinatology and Child Health, 7 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in S.R. Kottegoda's work include Birth, Development, and Health (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neonatal Respiratory Health Research (3 papers). S.R. Kottegoda is often cited by papers focused on Birth, Development, and Health (4 papers), Receptor Mechanisms and Signaling (4 papers) and Neonatal Respiratory Health Research (3 papers). S.R. Kottegoda collaborates with scholars based in Singapore, United Kingdom and United States. S.R. Kottegoda's co-authors include K. H. Ginzel, P.G. Adaikan, S. S. Ratnam, S.M.M. Karim, C. G. Uragoda, J. H. Burn, Gwenda R. Barer, Sabaratnam Arulkumaran, Ingemar Ingemarsson and Joan C. Mott and has published in prestigious journals such as The Journal of Physiology, The Journal of Urology and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

S.R. Kottegoda

36 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.R. Kottegoda Singapore 15 136 129 109 94 94 36 610
A.C.A. Glen United Kingdom 15 178 1.3× 213 1.7× 118 1.1× 79 0.8× 70 0.7× 31 883
S.G. Griffith United Kingdom 10 249 1.8× 156 1.2× 66 0.6× 40 0.4× 58 0.6× 11 693
Svetislav K. Vanov United States 13 109 0.8× 119 0.9× 37 0.3× 136 1.4× 26 0.3× 21 528
İhsan Bağcıvan Türkiye 14 153 1.1× 116 0.9× 65 0.6× 65 0.7× 79 0.8× 75 654
Montastruc Jl France 14 160 1.2× 129 1.0× 61 0.6× 78 0.8× 46 0.5× 87 686
Derek Chalmers United Kingdom 12 233 1.7× 267 2.1× 51 0.5× 42 0.4× 159 1.7× 18 870
T. Arnfred Denmark 15 207 1.5× 145 1.1× 32 0.3× 41 0.4× 50 0.5× 24 816
Erik Klinge Finland 17 306 2.3× 151 1.2× 352 3.2× 56 0.6× 201 2.1× 55 859
I. R. Innes Canada 15 171 1.3× 217 1.7× 27 0.2× 260 2.8× 45 0.5× 49 742
Albert O. Davies United States 13 177 1.3× 294 2.3× 52 0.5× 121 1.3× 96 1.0× 23 815

Countries citing papers authored by S.R. Kottegoda

Since Specialization
Citations

This map shows the geographic impact of S.R. Kottegoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.R. Kottegoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.R. Kottegoda more than expected).

Fields of papers citing papers by S.R. Kottegoda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.R. Kottegoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.R. Kottegoda. The network helps show where S.R. Kottegoda may publish in the future.

Co-authorship network of co-authors of S.R. Kottegoda

This figure shows the co-authorship network connecting the top 25 collaborators of S.R. Kottegoda. A scholar is included among the top collaborators of S.R. Kottegoda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.R. Kottegoda. S.R. Kottegoda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Мустафа, Омар, et al.. (2013). Severe hypertriglyceridaemia in Type 2 diabetes mellitus: beneficial effect of continuous insulin infusion. QJM. 106(4). 355–359. 25 indexed citations
2.
Loganath, A., et al.. (1988). Comparison of AFP and β-hCG levels in infiltrating duct mammary carcinoma at different stages of malignancy. Pathology. 20(3). 275–278. 4 indexed citations
3.
Ingemarsson, Ingemar, P.G. Adaikan, S. Arulkumaran, & S.R. Kottegoda. (1987). Effect of a Beta-Adrenoceptor Antagonist, Pindolol, on Human Uterine Smooth Muscle. Gynecologic and Obstetric Investigation. 24(3). 185–189. 3 indexed citations
4.
Tan, K.L., A. Loganath, Arul Mylvaganam, et al.. (1987). α‐Fetoprotein levels in fullterm and very low birthweight infants. Journal of Paediatrics and Child Health. 23(5). 285–287. 2 indexed citations
5.
Loganath, A., et al.. (1986). Elevated intravesicular fluid thyroid‐stimulating hormone concentration in hydratidiform mole. International Journal of Gynecology & Obstetrics. 24(3). 177–181. 1 indexed citations
6.
Ingemarsson, Ingemar, Sabaratnam Arulkumaran, & S.R. Kottegoda. (1985). Complications of Beta‐Mimetic Therapy in Preterm Labour. Australian and New Zealand Journal of Obstetrics and Gynaecology. 25(3). 182–189. 19 indexed citations
7.
Prasad, Rajendra, et al.. (1985). Midtrimester termination of pregnancy using intravaginal gemeprost (16, 16 dimethyl-trans delta 2 PGE1 methyl ester, cervagem).. PubMed. 26(2). 199–202. 3 indexed citations
8.
Loganath, A., et al.. (1985). Cholesterol synthesizing enzymes in term human fetal amnion.. PubMed. 13(3). 143–6. 3 indexed citations
9.
Roy, A.C., et al.. (1985). Multimolecular forms of oxytocinase activity in the human uterus and their inhibition by prostaglandins and cyclic GMP. Prostaglandins Leukotrienes and Medicine. 18(2). 133–141. 3 indexed citations
10.
Goh, Victor Hng Hang, et al.. (1984). Maternal plasma estradiol and progesterone levels during therapeutic abortion induced by 16, 16 dimethyl PGE2 p-benzaldehyde semicarbazone ester. Prostaglandins Leukotrienes and Medicine. 14(2). 215–224. 1 indexed citations
11.
Ratnam, Sam, et al.. (1984). Anencephaly: a retrospective analysis in Singapore. 1976 to 1980.. Journal of Medical Genetics. 21(5). 350–354. 6 indexed citations
12.
Karim, S.M.M., et al.. (1984). Inhibition of platelet aggregation and antagonism of vasopressin-induced ECG changes in primates by a carboprostacyclin analogue, ZK 36374. Thrombosis Research. 33(3). 333–340. 12 indexed citations
13.
Kottegoda, S.R., P.G. Adaikan, & S.M.M. Karim. (1982). Reversal of vasopressin-induced coronary vasoconstriction by a PGE1 analogue (ONO 1206) in primates. Prostaglandins Leukotrienes and Medicine. 8(4). 343–348. 7 indexed citations
14.
Karim, S.M.M., et al.. (1981). Effect of pregnenolone‐16 alpha‐carbonitrile (PCN) on bilirubin clearance in man.. British Journal of Clinical Pharmacology. 11(1). 99–100. 29 indexed citations
15.
Uragoda, C. G. & S.R. Kottegoda. (1977). Adverser reactions to isoniazid on ingestion of fish with a high histamine content. Tubercle. 58(2). 83–89. 31 indexed citations
16.
Kottegoda, S.R.. (1968). Are the excitatory nerves to the circular muscle of the guinea-pig ileum cholinergic?. PubMed. 197(1). 17P–18P. 4 indexed citations
17.
Kottegoda, S.R. & Joan C. Mott. (1955). CARDIOVASCULAR AND RESPIRATORY ACTIONS OF 5‐HYDROXYTRYPTAMINE IN THE CAT. British Journal of Pharmacology and Chemotherapy. 10(1). 66–72. 11 indexed citations
18.
Ginzel, K. H. & S.R. Kottegoda. (1954). The action of 5‐hydroxytryptamine and tryptamine on aortic and carotid sinus receptors in the cat. The Journal of Physiology. 123(2). 277–288. 49 indexed citations
19.
Burn, J. H. & S.R. Kottegoda. (1953). Action of eserine on the auricles of the rabbit heart. The Journal of Physiology. 121(2). 360–373. 16 indexed citations
20.
Kottegoda, S.R.. (1953). STIMULATION OF ISOLATED RABBIT AURICLES BY SUBSTANCES WHICH STIMULATE GANGLIA. British Journal of Pharmacology and Chemotherapy. 8(1). 83–86. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.C.A. Glen Breakdown of academic impact, for papers by S.G. Griffith Breakdown of academic impact, for papers by Svetislav K. Vanov Breakdown of academic impact, for papers by İhsan Bağcıvan Breakdown of academic impact, for papers by Montastruc Jl Breakdown of academic impact, for papers by Derek Chalmers Breakdown of academic impact, for papers by T. Arnfred Breakdown of academic impact, for papers by Erik Klinge Breakdown of academic impact, for papers by I. R. Innes Breakdown of academic impact, for papers by Albert O. Davies
Rankless by CCL
2026